ArticleFrontiers in human neuroscience2025
Exoskeleton therapy in cerebral palsy: improved gait endurance without kinematic change.
Article in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cerebral palsy (CP) often leads to impairments in movement and posture, limiting functional mobility. Robotic-assisted gait training (RAGT) using powered exoskeletons has emerged as a novel approach to enhance gait in individuals with CP. However, evidence regarding its effectiveness, particularly in unassisted gait performance, remains limited and inconclusive. Methods: This study involved 44 ambulatory youth with bilateral hypertonic CP (GMFCS levels I-III), who underwent an intensive RAGT program using the EksoGT exoskeleton. The intervention consisted of 28 sessions (90 min each) over 8 weeks, with a 2 weeks mid-point break. Gait assessments were conducted before (T1) and after (T2) therapy using 3D motion analysis and the 6-minute walk test (6MWT). Primary outcomes included spatiotemporal parameters, gait symmetry, gait deviation index (GDI), and walking endurance. Results: Following the exoskeleton training, participants demonstrated a statistically significant improvement in gait efficiency, with 6MWT distances increasing from 375 to 418 m ( Conclusion: Intensive exoskeleton therapy significantly improved walking endurance but did not alter gait symmetry or kinematics in independently ambulatory youth with hypertonic CP. These - findings suggest that while exoskeleton assisted training enhances functional endurance, its impact on gait pattern may be limited. Further research should explore its broader benefits on quality of life, participation, and psychosocial outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.